Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by whisky11on May 07, 2021 1:54pm
111 Views
Post# 33153549

RE:RE:RE:Garbage

RE:RE:RE:Garbage=Jshaw9]I come back to check and reaffirm that I made the right decision in getting out of this stock.
also if there is a possibility I was wrong and that things are turning around and if there is a good entry point back into a promising company.
what made me post was the fact that the narrative hasn't changed on this board, everyone is still saying the same things and are blind to the fact nothing about this company has changed.


whisky11: only  garbage people comes here with their insulting language like yours.
What you want to see here? You can get  different date yeah that's for sure.
It's been told couple times already ,that we're waiting for phase 1, and it will be successful.
Phase 1 is confirmation of Studies performed  on small and big mammals  and bacteria for cancer and genetic safety.
The company cannot be changed but you could get some behavioural help and become close to humans.




<< Previous
Bullboard Posts
Next >>